| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |